Based on recent data, Eagle Pharmaceuticals, Inc. (EGRX) shows an Average True Range (ATR) of 0.47 and an Enterprise Value of 113.93M. Its average trading volume over the past 3 months is 1.01K, indicating liquidity. These fundamental metrics provide insight into EGRX's underlying financial health and market activity.
| ATR | 0.47 |
| Enterprise Value | 113.93M |
| Avg Vol (3 Months) | 1.01K |
| Avg Vol (10 Days) | 816.5 |
Eagle Pharmaceuticals, Inc. (EGRX) technical indicators as of May 20, 2026: the SMA 20 is -45.49%, SMA 50 at -50.91%, and SMA 200 at -55.9%. The RSI 14 value is 20.52, suggesting its current momentum. These technical analysis signals help assess EGRX's price trends and potential future movements.
| SMA 20 | -45.49% |
| SMA 50 | -50.91% |
| SMA 200 | -55.9% |
| RSI 14 | 20.52 |
Eagle Pharmaceuticals, Inc. (EGRX) stock performance overview as of May 20, 2026: The 52-week high is $3.87 (currently -85.91% below), and the 52-week low is $0.001 (currently 18.89% above). Over the past year, EGRX's performance is -93.45%, compared to the S&P 500's 10.75% change.
| 52-Week High | 3.87 |
| 52-Week High Chg | -85.91% |
| 52-Week Low | 0.0011 |
| 52-Week Low Chg | +18.89% |
| S&P 500 52-Week Chg | 10.75% |
According to market data, Eagle Pharmaceuticals, Inc. (EGRX) stock's recent performance metrics show that over the last month, EGRX is -77.15%, with a Year-to-Date (YTD) performance of -83.27%. Over the past year, the stock has seen a -93.45% change. These figures summarize EGRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.385 | 0.85 | 3 | 3.87 | 3.87 | 0.85 |
| Low | 0.0024 | 0.0011 | 0.0011 | 0.0011 | 0.0011 | 0.0011 |
| Performance | -2.77% | -77.15% | -85.34% | -80.94% | -93.45% | -83.27% |
According to current financial data, EGRX stock's P/E (TTM) ratio is 0.13, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for EGRX, including P/S (0.02), P/B (0.02), and P/FCF (0.16), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | EGRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 0.13 | -1.22 | 13.14 | 32.59 |
| P/S (TTM) | 0.02 | 3.69 | 6.11 | 5.98 |
| P/B (TTM) | 0.02 | 0 | 95.27 | 4.56 |
| P/FCF (TTM) | 0.16 | 82.71 | 3.87 | 31.68 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep